BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24234394)

  • 1. Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults.
    Michaelidis CI; Zimmerman RK; Nowalk MP; Fine MJ; Smith KJ
    J Gen Intern Med; 2014 Apr; 29(4):579-86. PubMed ID: 24234394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capsule commentary on Michaelidis et al., Cost-effectiveness of procalcitonin-guided antibiotic therapy for outpatient management of acute respiratory tract infections in adults.
    Davis-Ajami ML
    J Gen Intern Med; 2014 Apr; 29(4):646. PubMed ID: 24357012
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.
    Schuetz P; Balk R; Briel M; Kutz A; Christ-Crain M; Stolz D; Bouadma L; Wolff M; Kristoffersen KB; Wei L; Burkhardt O; Welte T; Schroeder S; Nobre V; Tamm M; Bhatnagar N; Bucher HC; Luyt CE; Chastre J; Tubach F; Mueller B; Lacey MJ; Ohsfeldt RL; Scheibling CM; Schneider JE
    Clin Chem Lab Med; 2015 Mar; 53(4):583-92. PubMed ID: 25581762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Evid Based Child Health; 2013 Jul; 8(4):1297-371. PubMed ID: 23877944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of procalcitonin-guided antibiotic use in community acquired pneumonia.
    Smith KJ; Wateska A; Nowalk MP; Raymund M; Lee BY; Zimmerman RK; Fine MJ
    J Gen Intern Med; 2013 Sep; 28(9):1157-64. PubMed ID: 23463457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
    Schuetz P; Wirz Y; Sager R; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bucher HC; Bhatnagar N; Annane D; Reinhart K; Branche A; Damas P; Nijsten M; de Lange DW; Deliberato RO; Lima SS; Maravić-Stojković V; Verduri A; Cao B; Shehabi Y; Beishuizen A; Jensen JS; Corti C; Van Oers JA; Falsey AR; de Jong E; Oliveira CF; Beghe B; Briel M; Mueller B
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD007498. PubMed ID: 29025194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial.
    Schuetz P; Christ-Crain M; Wolbers M; Schild U; Thomann R; Falconnier C; Widmer I; Neidert S; Blum CA; Schönenberger R; Henzen C; Bregenzer T; Hoess C; Krause M; Bucher HC; Zimmerli W; Müller B;
    BMC Health Serv Res; 2007 Jul; 7():102. PubMed ID: 17615073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost impact of PCT-guided antibiotic stewardship versus usual care for hospitalised patients with suspected sepsis or lower respiratory tract infections in the US: A health economic model analysis.
    Mewes JC; Pulia MS; Mansour MK; Broyles MR; Nguyen HB; Steuten LM
    PLoS One; 2019; 14(4):e0214222. PubMed ID: 31013271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis.
    Westwood M; Ramaekers B; Whiting P; Tomini F; Joore M; Armstrong N; Ryder S; Stirk L; Severens J; Kleijnen J
    Health Technol Assess; 2015 Nov; 19(96):v-xxv, 1-236. PubMed ID: 26569153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin-guided antibiotic therapy: a systematic review and meta-analysis.
    Soni NJ; Samson DJ; Galaydick JL; Vats V; Huang ES; Aronson N; Pitrak DL
    J Hosp Med; 2013 Sep; 8(9):530-40. PubMed ID: 23955852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a Chinese hospital system perspective.
    Stojanovic I; Schneider JE; Wei L; Hong Z; Keane C; Schuetz P
    Clin Chem Lab Med; 2017 Mar; 55(4):561-570. PubMed ID: 27658150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procalcitonin-guided antibiotic use vs a standard approach for acute respiratory tract infections in primary care.
    Briel M; Schuetz P; Mueller B; Young J; Schild U; Nusbaumer C; Périat P; Bucher HC; Christ-Crain M
    Arch Intern Med; 2008 Oct; 168(18):2000-7; discussion 2007-8. PubMed ID: 18852401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is procalcitonin-guided antimicrobial use cost-effective in adult patients with suspected bacterial infection and sepsis?
    Harrison M; Collins CD
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):265-72. PubMed ID: 25695167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procalcitonin for reduced antibiotic exposure in the critical care setting: a systematic review and an economic evaluation.
    Heyland DK; Johnson AP; Reynolds SC; Muscedere J
    Crit Care Med; 2011 Jul; 39(7):1792-9. PubMed ID: 21358400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in "real life": an international, multicenter poststudy survey (ProREAL).
    Albrich WC; Dusemund F; Bucher B; Meyer S; Thomann R; Kühn F; Bassetti S; Sprenger M; Bachli E; Sigrist T; Schwietert M; Amin D; Hausfater P; Carre E; Gaillat J; Schuetz P; Regez K; Bossart R; Schild U; Mueller B;
    Arch Intern Med; 2012 May; 172(9):715-22. PubMed ID: 22782201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum procalcitonin levels: comment on "Effectiveness and safety of procalcitonin-guided antibiotic therapy in lower respiratory tract infections in 'real life'".
    Gilbert D
    Arch Intern Med; 2012 May; 172(9):722-3. PubMed ID: 22782202
    [No Abstract]   [Full Text] [Related]  

  • 18. [Procalcitonin-guided algorithms of antibiotic therapy in community-acquired lower respiratory tract infections: a systematic review and meta-analysis of randomized controlled trials].
    Zhang L; Huang J; Xu T; Lin Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Apr; 35(4):275-82. PubMed ID: 22781200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care.
    Smedemark SA; Aabenhus R; Llor C; Fournaise A; Olsen O; Jørgensen KJ
    Cochrane Database Syst Rev; 2022 Oct; 10(10):CD010130. PubMed ID: 36250577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin-guided antibiotic use versus a standard approach for acute respiratory tract infections in primary care: study protocol for a randomised controlled trial and baseline characteristics of participating general practitioners [ISRCTN73182671].
    Briel M; Christ-Crain M; Young J; Schuetz P; Huber P; Périat P; Bucher HC; Müller B
    BMC Fam Pract; 2005 Aug; 6():34. PubMed ID: 16107222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.